Clinical trial registry record

Muscle Aging Evaluation

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 25, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06845748
Last registry update
February 25, 2025
Status
Not Yet Recruiting
Phase
Phase not reported
Sponsor
University of Milan
Enrollment
200
Countries
Italy
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · PREVENTION · NONE
Evidence population
Human clinical study registration
Participants
200
Population
ALL · 18 Years
Duration
2025-04-01 to 2027-10-01
Intervention
Physical activity Group
Comparator
Control Group
Outcomes measured
Change in handgrip strength at 12 and 48 weeks — Baseline, Week 12, and Week 48; Change in muscle mass — Baseline, Week 12, and Week 48; Change in Lower Limb Strength (Knee Extension Isometric Force, N) at 12 and 48 weeks — Baseline, Week 12, and Week 48; Change in Physical Performance (Six-Minute Walk Test, meters) at 12 and 48 weeks — Baseline, Week 12, and Week 48; Change in Functional Mobility (Chair Stand Test, repetitions) at 12 and 48 weeks — Baseline, Week 12, and Week 48; Change in Balance and Postural Control (Mini-BESTest Score) at 12 and 48 weeks — Baseline, Week 12, and Week 48; Change in Quality of Life (SF-12 Health Survey Score) at 12 and 48 weeks — Baseline, Week 12, and Week 48; Change in Cognitive Function (Trail Making Test, A & B) at 12 and 48 weeks — Baseline, Week 12, and Week 48; Change in Psychological Well-being (Profile of Mood States - POMS) at 12 and 48 weeks — Baseline, Week 12, and Week 48
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 100%Title contains controlled term: muscle aging. Abstract contains controlled term: muscle aging. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON